- Home
- Reagents
- Overview
- Primary Antibodies
- Overview
- Anti-Allergen Antibodies
- Anti-Coronavirus Antibodies
- Anti-Virus Antibodies
- Antibodies to Epitope Tags
- DNA/RNA Research Antibodies
- Immunotherapy Research Antibodies
- Murine Bispecific Antibody Reagents
- Neuroscience Research Antibodies
- Recombinant Antibodies from Human Patients
- Recombinant Isotype Controls
- Research-Grade Biosimilars
- Tumor Marker Antigens
- VivopureX™ Antibodies for In Vivo Research
- Secondary Antibodies
- Recombinant Proteins
- Services
- Our Technology
- About Us
- Antibody Resource
- News & Events
- How to Order
14
Products in this category:
Antibody Name [Clone]
Expected Species Reactivity
Applications
-
Anti-Covid-19 & SARS-CoV Nucleocapsid [1C7C7]SARS-CoV, SARS-CoV-2WB, ELISA, FC, IHC
-
Anti-NP [JS08]SARS-CoV-2SPR, WB, ELISA
-
Anti-NP [JS08]SARS-CoV-2SPR, WB, ELISA
-
Anti-NP [JS16]SARS-CoV-2SPR, WB, ELISA
-
Anti-NP [JS16]SARS-CoV-2SPR, WB, ELISA
-
Anti-S protein (RBD) [1E2]SARS-CoV-2neutralizing, SPR, ELISA
-
Anti-S protein (RBD) [5F8]SARS-CoV-2in vitro neutralization, SPR
-
Anti-S protein (RBD) [aRBD-2]SARS-CoV-2Blocking, neutralizing, SPR, ELISA
-
Anti-S protein (RBD) [aRBD-5]SARS-CoV-2Blocking, neutralizing, SPR, ELISA
-
Anti-S protein (RBD) [aRBD-7]SARS-CoV-2Blocking, neutralizing, SPR, ELISA
-
Anti-S protein (RBD) [STE90-C11]SARS-CoV-2biolayer interferometry, crystallography, in vitro inhibition, in vitro neutralization, in vivo protection, therapeutic, ELISA
-
Anti-S protein [P17]SARS-CoV-2in vivo, neutralizing, SPR, ELISA, IF
-
Anti-SARS-CoV-2 and SARS-CoV nucleocapsid [mBG17]SARS-CoV, SARS-CoV-2WB, ELISA, IF
-
Anti-SARS-CoV-2 nucleocapsid [mBG86]SARS-CoV-2WB, ELISA, IF